Weekly digest · ISO week 44

Post-viral research digest, week 44 2026: 37 new studies

26 October 2026 – 1 November 2026 · published 1 November 2026 · Subscribe

  1. Research Tracker
  2. Weekly Digest
  3. Week 44 2026

Between 26 October 2026 and 1 November 2026 the tracker indexed 37 new peer-reviewed studies and 9 clinical-trial updates across 8 post-viral and post-infectious conditions.

By the numbers

37new studies this issue
9trial updates this issue
539studies currently in the feeds
634clinical trials tracked
603biomarkers catalogued

Studies tracked = entries across the 8 condition feeds (each feed keeps a rolling window of recent PubMed results); trials tracked = ClinicalTrials.gov records in the current trial snapshot (last run 2026-11-01); biomarkers catalogued = marker entries across all OSMF biomarker atlases.

In this issue:

New studies by condition

ME/CFS 7 new

Full feed: ME/CFS research tracker

More pronounced diurnal cortisol rhythms are longitudinally associated with less fatigue in colorectal cancer survivors: A 12-month prospective cohort study.

Psychoneuroendocrinology · 30 October 2026 · Frenken, Koen G, Scheer, Frank A J L, Qian, Jingyi, Bours, Martijn J L et al. PubMed 42962653

Fatigue is amongst the most debilitating cancer-related symptoms, affecting up to one-third of colorectal cancer (CRC) survivors. Accumulating evidence implicates dysregulation of HPA axis as a potential mechanism contributing to chronic fatigue syndrome.

The Glymphatic-Meningeal Lymphatic System and Autophagy in ME/CFS and Long COVID: A Mechanistic Perspective.

International journal of molecular sciences · 27 October 2026 · Nemat-Gorgani, Mohsen, Jensen, Michael Anthony, Davis, Ronald Wayne PubMed 42942118

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Post-Acute Sequelae of SARS-CoV-2 infection (Long COVID) are complex multisystem disorders affecting 60-400 million individuals globally. They are considered post-infectious illnesses and share similar biological mechanisms, including immune dysregulation, orthostatic intolerance and cognitive dysfunction, highlighting a substantial overlap between the...

Stress-inducible WASF3 regulates brain metabolism and cognitive function.

Proceedings of the National Academy of Sciences of the United States of America · 27 October 2026 · Syed, Abu M, Ma, Jin, Wang, Ping-Yuan, Son, Youlim et al. PubMed 42945241

Wiskott-Aldrich syndrome protein family member 3 (WASF3) disrupts mitochondrial respiration and is induced in association with endoplasmic reticulum stress in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Because cognitive impairment is a hallmark of ME/CFS, we investigated the role of WASF3 in brain metabolism and function using WASF3 transgenic and knockout mouse models.

ME/CFS and the thalamus as a precision gate: what reversible thalamocortical connectivity reveals about central gain in post-infectious fatigue.

Journal of translational medicine · 27 October 2026 · Strube, Andreas PubMed 42934697

Kim and colleagues report a finding that is easy to understate: thalamic hyperconnectivity with sensorimotor and visuo-occipital cortices, present in patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) at baseline, shifts back toward the pattern seen in healthy controls after hyperbaric oxygen therapy and does so most in the patients who improve clinically. To my knowledge, this is the first...

CATCH-EVseq, an Ultra-Sensitive Capture Assay to Monitor Human Enterovirus RNA.

International journal of molecular sciences · 27 October 2026 · Germain, Arnaud, Hanson, Maureen R PubMed 42941838

The detection of low-abundance viral RNA in chronic or persistent infections remains a major challenge in virology, constrained by the sensitivity and specificity of traditional methods. One such infection, chronic enterovirus (EV) infection, has been proposed as a potential underlying factor in Myalgic Encephalomyelitis (ME), although this hypothesis remains debated.

Chronic Lyme / Post-Treatment Lyme Disease Syndrome 1 new

Full feed: Lyme / PTLDS research tracker

Gulf War Illness 1 new

Full feed: Gulf War Illness research tracker

Postural Orthostatic Tachycardia Syndrome (POTS) 2 new

Full feed: POTS research tracker

Evaluation and Management of Syncope in Pregnancy and Postpartum.

Obstetrics and gynecology clinics of North America · 28 October 2026 · Azeem, Nabila, Nunez-Pellot, Cristina, Crousillat, Daniela, Cain, M Ashley PubMed 42951440

Syncope and presyncope symptoms occur commonly in pregnancy. Evaluation of syncope should include careful history and physical examination to determine underlying etiology.

Mast Cell Activation Syndrome (MCAS) 23 new

Full feed: MCAS research tracker

Effect of a breathing mask on type 2 mediator responses to subzero exercise in individuals without asthma.

BMC research notes · 30 October 2026 · Hanstock, Helen, Ainegren, Mats, Andersson, Erik P, Bäckebjörk, Ella et al. PubMed 42958574

Current evidence suggests that heat and moisture-exchanging breathing masks (HME) protect against exercise-induced bronchoconstriction (EIB). We aimed to explore whether mast cell mediator release following exercise in subzero conditions is affected by the use of an HME.

The new revolution in the treatment of chronic urticaria, present and future of an effective and safe approach.

Italian journal of dermatology and venereology · 29 October 2026 · Giménez-Arnau, Ana M, Barei, Francesca, Salman, Andaç PubMed 42955719

Chronic spontaneous urticaria (CSU) is a heterogeneous mast cell-driven disease associated with a substantial burden on patients' quality of life. Although most patients achieve disease control with guideline-recommended therapies, a relevant proportion remains refractory, highlighting important unmet needs.

Perioperative Management of Coexisting Mast Cell Activation Syndrome and Malignant Hyperthermia Susceptibility: A Case Report and Novel Approach to Local Analgesia.

Case reports in anesthesiology · 29 October 2026 · Gearing, Peter Francis, Nack, Thomas, Liyanage, Dinuk, Martis, Walston Reginald et al. PubMed 42953382

The coexistence of mast cell activation syndrome (MCAS) and malignant hyperthermia (MH) presents a significant perioperative challenge due to combined risks of anaphylaxis and anaesthesia-related hypermetabolic crisis. We describe the successful anaesthetic management of a man in his 60 s with confirmed MCAS and a strong family history of MH who underwent excision of multiple malignant cutaneous lesions.

A pectic polysaccharide from Lonicera japonica alleviates DNCB-induced atopic dermatitis-like inflammation associated with gut microbial and metabolic alterations and reduced cutaneous JAK2/STAT3 activation and Th17 responses.

Journal of ethnopharmacology · 29 October 2026 · Jin, Mingzhu, Hu, Yue, Ding, Mengmeng, Cheng, Jiayue et al. PubMed 42957112

Lonicera japonica Thunb. (Jin Yin Hua) is a traditional medicinal herb widely used in East Asia for inflammatory disorders and is commonly included in herbal prescriptions for atopic dermatitis (AD).

Deciphering isonicotinylation and mast cell-associated pathogenic patterns in Duchenne muscular dystrophy: evidence from ensemble learning-driven multi-omics and

Frontiers in molecular biosciences · 28 October 2026 · Yu, Sunrui, Xu, Duojia, Hua, Yuting, Mo, Hangfeng et al. PubMed 42947810

Duchenne muscular dystrophy (DMD) is dystrophin-deficiency skeletal and cardiac muscle disease. Protein post-translational modification (PTM) and aberrant immune cell activation play a key role in its pathogenesis.

Somatic Blood Mosaicism and Psychiatric Disease: Current Evidence and Causal Limits.

Genes · 27 October 2026 · Belbe, Andrada-Adelaida, Pîrlog, Lorin-Manuel, Pilatec, Alissia-Nicoleta, Militaru, Mariela-Sanda et al. PubMed 42938342

Somatic blood mosaicism is an established feature of ageing and a heterogeneous marker of haematologic cancer and inflammatory and vascular risk, but its psychiatric evidence base remains small. This structured critical narrative review evaluates mutation-defined clonal haematopoiesis, clonal haematopoiesis of indeterminate potential (CHIP), autosomal mosaic chromosomal alterations (mCAs), and sex-chromosome loss...

Shared mediators, divergent networks: a tissue-response hypothesis for discordant phenotypes in chronic spontaneous urticaria and atopic dermatitis.

Frontiers in allergy · 27 October 2026 · Ye, Young-Min, Hide, Michihiro PubMed 42935749

Chronic spontaneous urticaria (CSU) and atopic dermatitis (AD) are pruritic inflammatory skin diseases that share partly overlapping mast-cell-related pathways, including IgE/FcεRI signaling, type 2 inflammation, neuroimmune signaling, and lipid mediator pathways. Yet they usually produce distinct phenotypes: transient wheals and angioedema in CSU and persistent eczematous lesions with inflammation in AD.

IL-33/ST2 signalling in pediatric food allergy and eosinophilic gastrointestinal disorders: a systematic review of human and preclinical evidence.

Frontiers in immunology · 27 October 2026 · Grama, Monica, Săsăran, Maria Oana, Stan Muntean, Ana, Coman, Delia et al. PubMed 42935742

Interleukin-33 (IL-33) is an epithelial-derived member of the IL-1 cytokine family that functions as an alarmin and signals through the ST2 receptor, upstream of type 2 inflammation. Together with thymic stromal lymphopoietin (TSLP) and IL-25, it constitutes an epithelial alarmin triad that orchestrates barrier-related immune responses.

Colonic Mast Cell Density and Diarrhoea: Evidence Against a Threshold Effect in Biopsies From 3508 Patients.

Alimentary pharmacology & therapeutics · 27 October 2026 · Langreiter, Marlena, Genta, Robert M, Schreiner, Philipp PubMed 42936909

Elevated mast cell (MC) counts in colonic biopsies are frequently observed in patients with chronic diarrhoea or unspecific abdominal symptoms, potentially leading to a diagnosis of mast cell activation syndrome. However, the clinical relevance of MC quantification in this setting remains controversial.

Beyond Neuroinflammation: Targeting the Microbe-Barrier-Brain Axis Through Precision Nutrition in Neurological Long COVID (Neuro-PASC).

Nutrients · 27 October 2026 · Velázquez De Castro-Bono, Amador, Castro-Luna, Gracia, Guil-Guerrero, José Luis PubMed 42942991

Post-acute Neurological Sequelae of SARS-CoV-2 infection (Neuro-PASC) contribute substantially to Long COVID-related disability, with cognitive impairment, chronic fatigue, dysautonomia, and neuropsychiatric symptoms among its most debilitating manifestations. Although its pathogenesis remains incompletely understood, evidence implicates persistent immune activation, intestinal barrier dysfunction, microbiota...

Triterpenoid Exposure and HO-1 Blockade Sensitize Neoplastic Mast Cells Against Midostaurin and Avapritinib.

Cells · 26 October 2026 · John, Max Vincent, Filik Schüppler, Yüksel, Witzeneder, Nadine, Schneeweiss-Gleixner, Mathias et al. PubMed 42929870

Advanced systemic mastocytosis (advSM), including aggressive SM (ASM), SM with an associated hematologic neoplasm (SM-AHN) and mast cell leukemia (MCL), are rare, mostly KIT D816V-driven malignancies with a poor prognosis. KIT D816V-targeting drugs, such as midostaurin or avapritinib, can induce hematologic responses in most patients with advSM.

Microbial serotonin signalling axes in irritable bowel syndrome: integrative molecular crosstalk among enterochromaffin cells, gut microbiota, neuroimmune circuits, and precision therapeutic engineering.

Archives of microbiology · 26 October 2026 · Mehra, Ravinder Kumar, Singh, Bhanu Pratap, Siddiqui, Shakir, Aldawsari, Mohammed F et al. PubMed 42928090

Irritable bowel syndrome (IBS) is a common, often disabling disorder of gut-brain interaction whose molecular basis remains incompletely defined, leaving diagnosis largely symptom-based and treatment largely non-mechanistic. We argue that the serotonin (5-hydroxytryptamine; hereafter 5-HT, the primary term used throughout, with "serotonin" retained in less technical contexts) signalling axis-positioned at the...

Inositol hexakisphosphate kinase 1 regulates polyphosphate synthesis by maintaining V-ATPase-dependent secretory granule acidification.

The Journal of biological chemistry · 26 October 2026 · Mallick, Manisha, Bhandari, Rashna PubMed 42933572

Polyphosphate (polyP), a linear polymer of orthophosphate residues, is enriched in secretory granules in specialised mammalian cell types including platelets and mast cells. Although polyP released during activation and degranulation of these cells has been shown to promote blood clotting and inflammation, little is known about the mechanisms governing polyP synthesis in these granules.

Enhancing Surface Icephobic Performance via Spontaneous Fracture Characteristics of Ice Crystals Regulated by Structural Scale Under Shear Flow Conditions.

Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 26 October 2026 · Jiang, Jiawei, Shen, Yizhou, Xu, Yangjiangshan, Xiang, Junxian et al. PubMed 42928058

Icephobic surfaces are conventionally designed by minimizing ice adhesion; however, whether this strategy remains valid under aerodynamic shear remains poorly understood. Here, we reveal that an external flow field fundamentally alters ice adhesion dynamics by inducing the spontaneous fracture and detachment of ice crystals through aerodynamic shear forces.

Other post-viral and post-infectious syndromes 3 new

Full feed: Other post-viral research tracker

One trigger, two systems: post-infectious severe Guillain-Barre syndrome with concurrent central nervous system demyelination": a case report.

Oxford medical case reports · 26 October 2026 · Numan, Mohammad, Alhatou, Mohammad, Hussain, Zaeem, Hussain, Maidah et al. PubMed 42928892

Combined central and peripheral demyelination is a rare but serious neurological condition that is associated with poor outcomes. We report a 31-year-old male presenting with rapidly progressive Acute inflammatory demyelinating polyradiculoneuropathy (AIDP) variant of Guillain-Barré syndrome following an upper respiratory tract infection.

No new studies this window for: Long COVID, PACVS.

Trial activity

ClinicalTrials.gov records whose registry entry was last updated between 26 October 2026 and 1 November 2026. A registry update can be anything from a status change to an edited contact field; status shown is as of the tracker snapshot.

NCTTrialStatusPhaseAgentsUpdated
NCT07388550Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)
Long COVID
Not Yet RecruitingPhase 1Keytruda2026-10-30
NCT06907251Dapagliflozin for Long COVID Syndrome
Long COVID
Not Yet RecruitingPhase 3Dapagliflozin2026-10-30
NCT07523113ME/CFS Brain Fog: Cognitive Rehabilitation Trial
ME/CFS
RecruitingNot applicableProcessing Speed Training, In-Session Instrumental Activities Of Daily Living Training, Transfer Package2026-10-29
NCT06095297Long COVID Brain Fog: Cognitive Rehabilitation Trial
Long COVID
Active Not RecruitingNot applicableProcessing Speed Training, In-Lab Instrumental Activities Of Daily Living Training, In-Lab Brain Health Training2026-10-29
NCT07600320Fareon Open Label Device Clinical Trial
Other post-viral
Enrolling By InvitationNot applicableFareon Device2026-10-28
NCT07597902SARS-CoV-2 and Herpesvirus Inhibition for Ending Long COVID Dysfunction
Long COVID
RecruitingPhase 2Valacyclovir, Celecoxib, Paxlovid (Nirmatrelvir/Ritonavir)2026-10-28
NCT06953661Ultrasound Guided Stellate Ganglion Block in Postural Tachycardia Syndrome
Other post-viral
RecruitingNot applicableStellate Ganglion Block, Ropivacaine, Normal Saline2026-10-28
NCT07899346Study of VYD2311 for the Treatment of Adults With Long-COVID or Post-Vaccination Syndrome
Long COVID, PACVS
Not Yet RecruitingPhase 2Vyd23112026-10-27
NCT05350774Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2
Other post-viral
Enrolling By InvitationPhase 2Iv Normal Saline, Iv Immunoglobulin2026-10-26

Browse all tracked trials: clinical trials tracker.

Get the digest every week

The same issue goes out by email on Substack. RSS and JSON Feed are available for readers and aggregators.

Subscribe on SubstackRSS feedJSON Feed

Cite this issue

Open Source Medicine Foundation. Post-viral research digest, week 44 2026: 37 new studies. Published 1 November 2026. https://research.opensourcemed.info/digest/2026-W44.html

Issues are regenerated from the live tracker data within their week and frozen afterwards; the snapshot behind this page is at data/2026-W44.json.

Disclaimer. This digest is an automated, unreviewed listing of newly indexed PubMed records and ClinicalTrials.gov registry updates compiled by the Open Source Medicine Foundation. Inclusion is not endorsement; abstracts are excerpted verbatim from PubMed and may contain errors. It is not medical advice. Discuss any treatment decision with a qualified clinician.